Company profile for Denovo Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development. The core technology is the industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. This technology is especially useful for late stage clinical drugs that have completed trials with unsatisfactory efficacy. By identifying bioma...
Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development. The core technology is the industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. This technology is especially useful for late stage clinical drugs that have completed trials with unsatisfactory efficacy. By identifying biomarkers correlated to patients' responsiveness to drug candidates retrospectively, our technology enables biotech and pharmaceutical companies to design new clinical trials in a targeted patient population.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10240 Science Center Dr #120, San Diego, CA 92121
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/09/11/3148427/0/en/A-Landmark-Pivotal-Study-Applying-Precision-Medicine-to-Psychiatry-with-Denovo-s-DB104-liafensine-for-Treatment-Resistant-Depression-Published-in-JAMA-Psychiatry.html

GLOBENEWSWIRE
11 Sep 2025

https://www.globenewswire.com/news-release/2025/08/14/3133284/0/en/Denovo-Biopharma-LLC-to-Participate-in-Upcoming-Investor-Events.html

GLOBENEWSWIRE
14 Aug 2025

https://www.globenewswire.com/news-release/2025/06/23/3103263/0/en/Denovo-Biopharma-LLC-Enters-into-an-Exclusive-Out-License-Agreement-with-Chuang-Yi-Global-Asset-Management-Co-Ltd-for-Biomarker-Guided-DB104-liafensine-in-Patients-with-Treatment-R.html

GLOBENEWSWIRE
23 Jun 2025

https://www.globenewswire.com/news-release/2025/06/06/3095010/0/en/Denovo-Biopharma-Announces-Formation-of-Neuroscience-Scientific-Advisory-Board-to-Advance-Precision-Medicine-in-Depression.html

GLOBENEWSWIRE
06 Jun 2025

https://www.prnewswire.com/news-releases/fda-grants-fast-track-designation-for-biomarker-guided-db104-liafensine-in-patients-with-treatment-resistant-depression-trd-302270948.html

PR NEWSWIRE
09 Oct 2024

https://www.prnewswire.com/news-releases/denovo-biopharma-llc-to-present-positive-phase-2b-enlighten-trial-data-for-dgm4-biomarker-guided-db104-liafensine-treatment-for-treatment-resistant-depression-at-the-ascp-2024-annual-meeting-302152321.html

PR NEWSWIRE
28 May 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty